Aaron Ciechanover

From WikiMD's WELLNESSPEDIA

File:Aaron Ciechanover Speaking at the Technion, February 2018.jpg
Aaron Ciechanover Speaking at the Technion, February 2018

Aaron Ciechanover (born October 1, 1947) is an Israeli biochemist who, along with Avram Hershko and Irwin Rose, was awarded the Nobel Prize in Chemistry in 2004 for the discovery of ubiquitin-mediated protein degradation. This groundbreaking work has had significant implications for understanding the cell cycle, oncogenesis, and various other cellular processes.

Early Life and Education[edit]

Aaron Ciechanover was born in Haifa, Mandatory Palestine (now Israel). He completed his undergraduate studies in medicine at the Hebrew University of Jerusalem and earned his M.Sc. in biochemistry from the same institution. He later pursued a Ph.D. in biochemistry at the Technion – Israel Institute of Technology under the supervision of Avram Hershko.

Research and Discoveries[edit]

Ciechanover's most notable contribution to science is his work on the ubiquitin-proteasome system. This system is crucial for the regulated degradation of proteins within the cell. The process involves tagging unwanted or damaged proteins with a small protein called ubiquitin, which signals for their destruction by the proteasome, a large protein complex.

Ubiquitin-Proteasome System[edit]

The ubiquitin-proteasome system is essential for maintaining cellular homeostasis by regulating the concentration of specific proteins and degrading misfolded proteins. This system plays a critical role in various cellular processes, including the cell cycle, DNA repair, and immune response.

Awards and Honors[edit]

In addition to the Nobel Prize in Chemistry, Ciechanover has received numerous awards and honors for his contributions to science, including the Albert Lasker Award for Basic Medical Research and the Israel Prize in biochemistry.

Academic and Professional Career[edit]

Ciechanover has held various academic positions throughout his career. He is a Distinguished Research Professor in the Faculty of Medicine at the Technion – Israel Institute of Technology. He has also been involved in numerous scientific advisory boards and has contributed to various scientific journals.

Personal Life[edit]

Aaron Ciechanover is married and has children. He continues to reside in Haifa, where he remains active in the scientific community.

See Also[edit]

References[edit]


External Links[edit]




Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss blog | Philadelphia weight loss blog | Sleep medicine and sleep apnea services | W8MD MedSpa and wellness | Weight loss prescriptions

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.